IMM 1.59% 31.0¢ immutep limited

Patty no nead to get too defensive, yes business analysis is due...

  1. 51 Posts.
    Patty no nead to get too defensive, yes business analysis is due diligence however with a stock like this ie Bio Tech I think most punters realise that it's relevence is debateable particularly at this point in time. By all means do as meany charts / scenarios as you want If it makes you feel comfortable.

    Directors discretion and responsibilities requires them these days to be particularly careful and conservative with market forecasts. Just look at the need for treating Ovarian Cancer and how this technology fits in with the dire need.

    Do you own DD but for mine this has potential way beyond your simple analysis
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.